Generex to Launch First Oral Insulin

Generex, a small independent pharmaceutical company, is set to launch the first ever commercially available non-injectable insulin in Ecuador in the beginning of 2006. Oral-lyn, as the insulin spray is branded, is applied to the mouth by the company's proprietary RapidMist delivery system.

For years, the big pharmaceutical companies have been chasing the holy grail of diabetes therapies – non-injectable insulin. A range of such products are set to explode on to the market in the next few years, ensuring a bitter grapple for market share.

The company is launching in Ecuador first due to their more relaxed drug trial requirements and they expect to use the revenue from the sale of the drug in South America to fund more expensive phase III trials for the US and Europe.

via: In Pharma Technologist